CLINICAL_TRIALS
trial_result
· 2025-10-24
Clinical Trial Update: A Study to Assess Vamorolone in Boys Ages 2 to <4 Years and 7 to <18 Years With Duchenne Muscular Dystrophy (DMD) [Phase 2]
Summary
Phase 2 trial of vamorolone in boys aged 2 to <4 and 7 to <18 with Duchenne Muscular Dystrophy completed; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Santhera Pharmaceuticals | Conditions: Duchenne Muscular Dystrophy | Phase 2 | Status: COMPLETED | Results posted: 2025-10-24